<p>
Hyderabad-based pharma company Hetero said on Monday it has received emergency use approval from the Indian health authorities to make a generic version of Swiss giant Roche Holding AG&#39;s drug Tocilizumab used for treating COVID-19 patients.</p>
<p>
Hetero is likely to make the cheaper version of Tocilizumab available in Indian market by the end of the month under the local brand name Tocira. The drug will be produced at the company&rsquo;s plant in Hyderabad.</p>
<p>
Tocilizumab has been in high demand due to the surge in COVID-19 cases and there is a shortage of the drug worldwide.</p>
<p>
Roche&#39;s blockbuster arthritis drug, tocilizumab, cuts the risk of death among patients hospitalised with severe COVID-19. It also cuts the recovery time and reduces the need for mechanical ventilation.</p>
<p>
Hetero, also makes medicines such as remdesivir and favipiravir used for treating COVID-19 patients.</p>
The intensifying cutting of trees for firewood in Pakistan-occupied Gilgit-Baltistan (PoGB) is not only worsening…
A group of retired judges, bureaucrats, Army officials and other civil society members have penned…
Israel and Slovakia signed a 2 billion shekel (USD 582 million) agreement on Monday to…
Protests against the prolonged road closures in Kurram persisted on Sunday, as residents held a…
Sikyong Penpa Tsering, the political leader of the Central Tibetan Administration (CTA), has successfully concluded…
The World Uyghur Congress (WUC) has strongly condemned the Chinese government's recent decision to impose…